Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rouveix

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Clinical and Experimental Immunology|August 1, 1990
T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDSM Levacher, S Tallet, M C Dazza, et al.
Fundamental & Clinical Pharmacology|July 1, 1998
Effect of a single oral dose of two erythromycin ethylsuccinate formulations on gastric emptying in healthy volunteers: a scintigraphic studyF Delatour, D Le Guludec, F Caron, et al.
Physiological Research|January 1, 1997
The effect of drugs on the mortality of mice inoculated with Friend leukaemia virus or toxoplasma gondiiM Starec, M Sinet, P Kodym, et al.
British Journal of Clinical Pharmacology|August 1, 1989
Divided-dose kinetics of mefloquine in manG Franssen, B Rouveix, J Lebras, et al.
Clinical and Experimental Immunology|November 1, 1983
Characterization of immunological depression in mice exposed to normobaric oxygenM Levacher-Place, M A Gougerot-Pocidalo, B Rouveix, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1991
Immune status and survival of opiate- and cocaine-treated mice infected with Friend virusM Starec, B Rouveix, M Sinet, et al.
Acta Haematologica|January 1, 1989
Amodiaquine-induced agranulocytosis: report of a case with in vitro studies of granulocyte-macrophage progenitor cellsJ P Aymard, B Rouveix, R Ferry, et al.
Therapie|March 10, 2001
[Antibacterial activity of urine after administration of ofloxacin for 5 days]H Drugeon, M L Veyries, M Levacher, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1996
Effects of two oral erythromycin ethylsuccinate formulations on the motility of the small intestine in human beingsF Caron, M Bouaniche, F Delatour, et al.
International Journal of Pharmaceutics|November 24, 1999
Controlled release of vancomycin from poloxamer 407 gelsM L Veyries, G Couarraze, S Geiger, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Clinical and Experimental Immunology|August 1, 1990
T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDSM Levacher, S Tallet, M C Dazza, et al.
Fundamental & Clinical Pharmacology|July 1, 1998
Effect of a single oral dose of two erythromycin ethylsuccinate formulations on gastric emptying in healthy volunteers: a scintigraphic studyF Delatour, D Le Guludec, F Caron, et al.
Physiological Research|January 1, 1997
The effect of drugs on the mortality of mice inoculated with Friend leukaemia virus or toxoplasma gondiiM Starec, M Sinet, P Kodym, et al.
British Journal of Clinical Pharmacology|August 1, 1989
Divided-dose kinetics of mefloquine in manG Franssen, B Rouveix, J Lebras, et al.
Clinical and Experimental Immunology|November 1, 1983
Characterization of immunological depression in mice exposed to normobaric oxygenM Levacher-Place, M A Gougerot-Pocidalo, B Rouveix, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1991
Immune status and survival of opiate- and cocaine-treated mice infected with Friend virusM Starec, B Rouveix, M Sinet, et al.
Acta Haematologica|January 1, 1989
Amodiaquine-induced agranulocytosis: report of a case with in vitro studies of granulocyte-macrophage progenitor cellsJ P Aymard, B Rouveix, R Ferry, et al.
Therapie|March 10, 2001
[Antibacterial activity of urine after administration of ofloxacin for 5 days]H Drugeon, M L Veyries, M Levacher, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1996
Effects of two oral erythromycin ethylsuccinate formulations on the motility of the small intestine in human beingsF Caron, M Bouaniche, F Delatour, et al.
International Journal of Pharmaceutics|November 24, 1999
Controlled release of vancomycin from poloxamer 407 gelsM L Veyries, G Couarraze, S Geiger, et al.
Pageof 6